PAUL N. CASALE, M.D.; RICHARD B. DEVEREUX, M.D.; MARK MILNER, M.D.; GERARDO ZULLO, B.S.; GREGORY A. HARSHFIELD, Ph.D.; THOMAS G. PICKERING, M.D., Ph.D.; JOHN H. LARAGH, M.D.
CASALE PN, DEVEREUX RB, MILNER M, ZULLO G, HARSHFIELD GA, PICKERING TG, et al. Value of Echocardiographic Measurement of Left Ventricular Mass in Predicting Cardiovascular Morbid Events in Hypertensive Men. Ann Intern Med. 1986;105:173-178. doi: 10.7326/0003-4819-105-2-173
Download citation file:
Published: Ann Intern Med. 1986;105(2):173-178.
To assess whether echocardiographic and electrocardiographic detection of left ventricular hypertrophy could predict cardiovascular morbid events in patients with uncomplicated essential hypertension, we followed 140 men for a mean of 4.8 years. Initial echocardiographic measurements of left ventricular mass were normal (< 125 g/m2 body surface area) in 111 patients and revealed hypertrophy in 29 patients. Morbid events occurred in more patients with hypertrophy on echocardiography (7 of 29,4.6/100 patient-years) than with normal ventricular mass (7 of 111,1.4/100 patient-years; p < 0.01). Electrocardiography showed hypertrophy in too few patients to be of predictive value. Multiple logistic regression analysis showed that left ventricular mass index had the highest independent relative risk for future events and that systolic and diastolic pressures and age had slightly lower relative risks. In men with mild uncomplicated hypertension, left ventricular hypertrophy detected by echocardiography identifies patients at high risk for cardiovascular morbid events and is a significant risk factor for future morbid events independent of age, blood pressure, or resting ventricular function.
Learn more about subscription options.
Register Now for a free account.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only